Skip to content

Released Aug 6, 2020, before the open

10-Q filed Aug 6, 2020, 37 days after period end · 0001104659-20-091145

Q2 2020 · 10-Q
Revenue—
Net Income-$6.37MN/M vs Q2 2019N/M vs Q1 2020
EPS Diluted-$0.13N/M vs Q2 2019N/M vs Q1 2020
Operating Income-$4,222,519N/M
Operating Cash Flowderived-$4,079,248N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2020Q2 2019Q2 2018Q2 2017
Revenue—$0.00$0.00$0.00
Net Income-$6.37M-$3.43M-$3.26M-$6.09M
EPS Diluted-$0.13-$0.14-$0.15-$0.31

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR